LV12251A - 2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai - Google Patents

2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai

Info

Publication number
LV12251A
LV12251A LV980231A LV980231A LV12251A LV 12251 A LV12251 A LV 12251A LV 980231 A LV980231 A LV 980231A LV 980231 A LV980231 A LV 980231A LV 12251 A LV12251 A LV 12251A
Authority
LV
Latvia
Prior art keywords
prophylaxis
alzheimer
phenyl
treatment
benzisoseleazol
Prior art date
Application number
LV980231A
Other languages
English (en)
Other versions
LV12251B (lv
Inventor
Ikuo Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of LV12251A publication Critical patent/LV12251A/lv
Publication of LV12251B publication Critical patent/LV12251B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-98-231A 1996-08-27 1998-10-22 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai LV12251B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (2)

Publication Number Publication Date
LV12251A true LV12251A (lv) 1999-04-20
LV12251B LV12251B (lv) 1999-08-20

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-231A LV12251B (lv) 1996-08-27 1998-10-22 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai

Country Status (29)

Country Link
US (1) US5948800A (lv)
EP (1) EP0826370B1 (lv)
KR (1) KR20000035859A (lv)
CN (1) CN1112922C (lv)
AT (1) ATE219361T1 (lv)
AU (2) AU3866997A (lv)
BR (1) BR9711259A (lv)
CA (1) CA2213794C (lv)
CZ (1) CZ295364B6 (lv)
DE (2) DE59707550D1 (lv)
DK (1) DK0826370T3 (lv)
EE (1) EE03953B1 (lv)
ES (1) ES2177849T3 (lv)
FI (1) FI119622B (lv)
HK (1) HK1020317A1 (lv)
HU (1) HU225264B1 (lv)
IL (1) IL127113A (lv)
LT (1) LT4602B (lv)
LV (1) LV12251B (lv)
NO (1) NO312812B1 (lv)
NZ (1) NZ332292A (lv)
PL (1) PL188481B1 (lv)
PT (1) PT826370E (lv)
SI (1) SI9720060B (lv)
TR (1) TR199700858A2 (lv)
TW (1) TW501925B (lv)
UA (1) UA59367C2 (lv)
WO (2) WO1998008511A1 (lv)
ZA (1) ZA977644B (lv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0729756T3 (da) * 1993-10-27 2000-06-05 Daiichi Seiyaku Co Granulært farmaceutisk præparat
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
HK1020317A1 (en) 2000-04-14
UA59367C2 (uk) 2003-09-15
CN1112922C (zh) 2003-07-02
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
FI982689A0 (fi) 1998-12-11
NO973912L (no) 1998-03-02
SI9720060B (en) 2001-12-31
ZA977644B (en) 1999-02-26
TW501925B (en) 2002-09-11
LV12251B (lv) 1999-08-20
HUP9903213A1 (en) 2000-07-28
KR20000035859A (ko) 2000-06-26
FI982689A (fi) 1998-12-11
PT826370E (pt) 2002-10-31
EE9900007A (et) 1999-06-15
ATE219361T1 (de) 2002-07-15
PL321796A1 (en) 1998-03-02
BR9711259A (pt) 1999-08-17
US5948800A (en) 1999-09-07
HU225264B1 (en) 2006-08-28
LT4602B (lt) 2000-01-25
CZ295364B6 (cs) 2005-07-13
TR199700858A2 (xx) 1998-03-21
PL188481B1 (pl) 2005-02-28
NO973912D0 (no) 1997-08-26
DE59707550D1 (de) 2002-07-25
SI9720060A (sl) 1999-06-30
FI119622B (fi) 2009-01-30
AU3866997A (en) 1998-03-19
IL127113A0 (en) 1999-09-22
CZ31799A3 (cs) 1999-11-17
WO1998008831A1 (fr) 1998-03-05
IL127113A (en) 2003-07-06
AU725534B2 (en) 2000-10-12
EP0826370A1 (de) 1998-03-04
CA2213794A1 (en) 1998-02-27
EP0826370B1 (de) 2002-06-19
CA2213794C (en) 2006-10-03
NZ332292A (en) 2001-07-27
CN1223580A (zh) 1999-07-21
WO1998008511A1 (de) 1998-03-05
ES2177849T3 (es) 2002-12-16
LT99016A (en) 1999-10-25
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
NO312812B1 (no) 2002-07-08
EE03953B1 (et) 2003-02-17

Similar Documents

Publication Publication Date Title
LV12251A (lv) 2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
AU8392291A (en) Tachykinin agonists for treatment of alzheimer's disease
AU1808488A (en) Compounds for the treatment of alzheimer's disease
FI950909A (fi) Rasvahappojohdannaisia
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
NO924066L (no) Terapeutisk middel
DK0458287T3 (da) Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
IT1222395B (it) Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
DE59307982D1 (de) Verwendung von NADH und NADPH zur Herstellung eines Arzneimittels zur Behandlung von Morbus Alzheimer
EP0345247A3 (de) Verwendung von monosubstituierten selenorganischen Verbindungen zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
CA2078700A1 (en) Imidazolylmethyl-pyridines
HUP9701060A2 (hu) Darifenacint tartalmazó gyógyszerkészítmény kognitív zavarok kezelésére
DE69008466D1 (de) Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.
ATE229336T1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti